Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Patrick Reynolds

Showing results (61-70 of 188) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|October 28, 2010
Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, Min Kang, et al.
Cancer Research|May 17, 2012
Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastomaKelly C Goldsmith, Michelle Gross, Susan Peirce, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2014
DrugPath: a database for academic investigators to match oncology molecular targets with drugs in developmentEric D Shah, Brandon M A Fisch, Robert J Arceci, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2023
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignanciesAlexis C Boulter, Barry J Maurer, Meredith Pogue, et al.
Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.
Molecular Oncology|October 23, 2019
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastomaSrinivas Chava, C Patrick Reynolds, Anup S Pathania, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group studyKatherine K Matthay, C Patrick Reynolds, Robert C Seeger, et al.
Plos One|December 7, 2013
Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell linesWilliam A May, Rita S Grigoryan, Nino Keshelava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2015
Crizotinib Synergizes with Chemotherapy in Preclinical Models of NeuroblastomaKateryna Krytska, Hannah T Ryles, Renata Sano, et al.
The Journal of Clinical Investigation|August 22, 2007
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastomaLiping Song, Tasnim Ara, Hong-Wei Wu, et al.
Pageof 19

Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|October 28, 2010
Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, Min Kang, et al.
Cancer Research|May 17, 2012
Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastomaKelly C Goldsmith, Michelle Gross, Susan Peirce, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2014
DrugPath: a database for academic investigators to match oncology molecular targets with drugs in developmentEric D Shah, Brandon M A Fisch, Robert J Arceci, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2023
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignanciesAlexis C Boulter, Barry J Maurer, Meredith Pogue, et al.
Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.
Molecular Oncology|October 23, 2019
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastomaSrinivas Chava, C Patrick Reynolds, Anup S Pathania, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group studyKatherine K Matthay, C Patrick Reynolds, Robert C Seeger, et al.
Plos One|December 7, 2013
Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell linesWilliam A May, Rita S Grigoryan, Nino Keshelava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2015
Crizotinib Synergizes with Chemotherapy in Preclinical Models of NeuroblastomaKateryna Krytska, Hannah T Ryles, Renata Sano, et al.
The Journal of Clinical Investigation|August 22, 2007
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastomaLiping Song, Tasnim Ara, Hong-Wei Wu, et al.
Pageof 19